Redenlab

Redenlab is a neuroscience-focused health technology company that develops and deploys digital speech, language, swallowing, and audio biomarkers for clinical trials and healthcare research. The company provides software, analytics, protocol design, remote and in-clinic data capture, and statistical support to help sponsors measure treatment effects more objectively in neurological and neurodevelopmental disorders. Its platform is designed for use across Phase 0-IV studies and supports decentralized, at-home, and virtual trial models. Redenlab is positioned as a service-enabled platform business rather than a therapeutic drug developer, with particular strength in communication-based endpoints for neurodegenerative, neurodevelopmental, and psychiatric indications.